Deciphera Pharmaceuticals...

NASDAQ: DCPH · Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM

Deciphera Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
91.23M 83.51M 108.09M 81.39M 114.64M 64.74M 82.54M 109.7M 95.33M 87.06M 53.19M 90.95M 201.65M
Short-Term Investments
181.3M 222.71M 230.99M 247.35M 284M 259.75M 282.04M 274.15M 161.22M 198.57M 289.08M 304.4M 300.53M
Long-Term Investments
34.91M 46.7M 37.85M 60.68M 27.63M 14.55M 7.01M 9.21M 18.85M 41.95M 49.93M 55.6M 3.1M
Other Long-Term Assets
n/a 8.28M 3.34M 3.34M 3.28M 3.28M 3.28M 3.27M 3.11M 3.11M 3.1M 3.1M n/a
Receivables
32.68M 31.95M 27.55M 23.2M 22.44M 22.43M 23.28M 25.85M 23.15M 20.59M 18.05M 18.61M 21.82M
Inventory
21.1M 21.21M 27.11M 25.34M 25.53M 20.56M 19.13M 20.89M 19.63M 14.13M 7.25M 8.21M 7.09M
Other Current Assets
23.63M 21.72M 23.85M 27.77M 29.56M 25.48M 13.89M 17.94M 20.5M 18.66M 17.72M 14.98M 15.55M
Total Current Assets
349.94M 381.1M 417.58M 405.05M 476.16M 392.96M 420.88M 448.53M 319.83M 339.01M 385.29M 437.14M 546.63M
Property-Plant & Equipment
36.08M 37.49M 39.07M 40.55M 41.96M 43.25M 44.79M 46.03M 43.67M 45.41M 45.1M 44.72M 45.51M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
70.99M 92.47M 80.26M 104.57M 72.86M 61.08M 55.07M 58.51M 65.63M 90.47M 98.12M 103.42M 48.61M
Total Assets
420.93M 473.57M 497.84M 509.62M 549.02M 454.04M 475.95M 507.04M 385.46M 429.48M 483.42M 540.57M 595.25M
Account Payables
19.46M 26.48M 21.45M 18.21M 19.67M 18.61M 12.8M 16.23M 17.8M 13.13M 13.5M 14.02M 11.9M
Deferred Revenue
n/a 68.35M 63.46M 56.06M n/a n/a n/a n/a n/a 79.7M n/a n/a n/a
Short-Term Debt
3.57M 3.5M 3.44M 3.37M 3.3M 3.23M 3.17M 3.1M 2.93M 2.87M 2.66M 2.6M 2.54M
Other Current Liabilities
60.4M 1.95M 4.55M 3.4M 60.94M 64.62M 59.5M 55.21M 65.94M 1.07M 59.63M 49.43M 49.34M
Total Current Liabilities
83.43M 100.28M 92.89M 81.03M 83.91M 86.47M 75.47M 74.55M 86.67M 96.77M 75.79M 66.05M 63.79M
Long-Term Debt
21.45M 22.38M 23.27M 24.15M 25.02M 25.88M 26.71M 27.48M 27.23M 27.99M 27.17M 27.86M 28.44M
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
21.45M 22.38M 23.27M 24.15M 25.02M 25.88M 26.71M 27.48M 27.23M 27.99M 27.17M 27.86M 28.44M
Total Liabilities
104.88M 122.65M 116.17M 105.19M 108.94M 112.35M 102.18M 102.03M 113.9M 124.76M 102.96M 93.91M 92.23M
Total Debt
25.02M 25.88M 26.71M 27.52M 28.32M 29.11M 29.88M 30.58M 30.16M 30.86M 29.83M 30.46M 30.98M
Common Stock
821K 805K 799K 788K 785K 676K 674K 668K 586K 585K 583K 580K 579K
Retained Earnings
-1.47B -1.43B -1.38B -1.33B -1.28B -1.23B -1.19B -1.14B -1.1B -1.05B -966.04M -886.2M -815.77M
Comprehensive Income
98K 577K -896K -967K -181K -983K -2.04M -1.27M -563K 51K 165K 26K 43K
Shareholders Equity
316.05M 350.92M 381.67M 404.43M 440.08M 341.69M 373.78M 405.01M 271.56M 304.72M 380.46M 446.66M 503.01M
Total Investments
216.21M 269.41M 268.84M 308.03M 311.62M 274.3M 289.05M 283.36M 180.07M 240.52M 339.01M 360.01M 303.63M